chrX-47142352-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001135998.3(NDUFB11):c.427G>A(p.Asp143Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000091 in 1,208,819 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D143H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001135998.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDUFB11 | NM_001135998.3 | c.427G>A | p.Asp143Asn | missense_variant | 3/3 | ENST00000377811.4 | |
NDUFB11 | NM_019056.7 | c.457G>A | p.Asp153Asn | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDUFB11 | ENST00000377811.4 | c.427G>A | p.Asp143Asn | missense_variant | 3/3 | 1 | NM_001135998.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111512Hom.: 0 Cov.: 23 AF XY: 0.0000593 AC XY: 2AN XY: 33710
GnomAD3 exomes AF: 0.00000555 AC: 1AN: 180153Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 64795
GnomAD4 exome AF: 0.00000820 AC: 9AN: 1097307Hom.: 0 Cov.: 31 AF XY: 0.00000827 AC XY: 3AN XY: 362743
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111512Hom.: 0 Cov.: 23 AF XY: 0.0000593 AC XY: 2AN XY: 33710
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2024 | The c.457G>A (p.D153N) alteration is located in exon 3 (coding exon 3) of the NDUFB11 gene. This alteration results from a G to A substitution at nucleotide position 457, causing the aspartic acid (D) at amino acid position 153 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Mitochondrial complex 1 deficiency, nuclear type 30 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Jun 13, 2019 | This NDUFB11 variant has not been reported in ClinVar nor the literature, to our knowledge. Additionally, this variant (rs374083393) is rare (<0.1%) in a large population dataset (gnomAD: 1/201877 total alleles; 0.0004945%; no homozygotes; no hemizygotes). Two bioinformatic tool queried predict that this substitution would be probably damaging, and the aspartic acid residue at this position is evolutionarily conserved across all species assessed. Bioinformatic analysis predicts that this missense variant would not affect normal exon 3 splicing, although this has not been confirmed experimentally to our knowledge. The clinical significance of c.457G>A is uncertain at this time. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at